Alogliptin May Be Associated With Lower Fracture Risk Compared With Linagliptin, Saxagliptin
The DPP-4 inhibitor alogliptin may be associated with a lower risk for bone fracture compared with linagliptin and saxagliptin.
Routine vitamin D and calcium supplementation in older adults is not supported for lowering the incidence of osteoporosis-related fractures.
Among older adults with functional limitations, a long-term physical activity program was not associated with reduced frailty risk.
Lower rates for hip fractures in women are linked to high intake of fermented milk products, along with fruits and vegetables.